Skip to content

Evaluation of short course versus long course radiotherapy regimens

Evaluation of short course versus long course hypo fractionated palliative radiotherapy regimens in locally advanced head and neck cancers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047367
Enrollment
30
Registered
2022-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Long course hypo fractionated palliative radiotherapy regimens in locally advanced head and neck cancers: Patients will receive a long course hypo fractionated palliative radiotherapy r

Sponsors

Postgraduate istitute of medical education and research, chadigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients with histopathological proven head and neck squamous cell carcinoma. 2.Locally advanced stage IV HNCs suitable for palliative radiotherapy treatment only.

Exclusion criteria

Exclusion criteria: 1.Patient treated previously with chemotherapy or radiotherapy. 2.Patients having diagnosis of carcinoma nasopharynx. 3.Patients having co-morbidities like uncontrolled diabetes, hypertension, thyroid disorders.

Design outcomes

Primary

MeasureTime frame
1. Quality of life assessment 2. Evaluation acute radiation toxicities 3. Response assessmentTimepoint: Patients will be assessed for quality of life before starting treatment and then at 6 monthly follow up. Patients will also be assessed weekly for radiation toxicities during treatment. Response to treatment will be assessed at 6 months.

Secondary

MeasureTime frame
Radiotherapy interruptions during treatmentTimepoint: Both treatment groups will be assessed for treatment interruptions- Group 1- After 1 week of start of treatment. Group 2-After 1 week and 2 weeks from start of treatment.

Countries

India

Contacts

Public ContactDr Ashutosh

Post graduate institute of medical education and reseach, Chandigarh

dramitbahl@yahoo.com6283774431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026